| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.06 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.23 | 0.06 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.24 | 0.06 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |